The cost-effectiveness of adalimumab (HUMIRA®) in patients with rheumatoid arthritis (RA) in Denmark

被引：0
|
作者：
Aagren, M.
Davies, A.
Winding, B.
Cifaldi, M.
Pang, F.
机构：
[1] Muusmann Res & Consulting, Copenhagen, Denmark
[2] United Biosource Corp, London, England
[3] Abbott Denmark AS, Gentofte, Denmark
[4] Abbott Labs, Chicago, IL USA
[5] Abbott Labs Ltd, Maidenhead, Berks, England
来源：
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 2006年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：15 / 15
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of adalimumab (Humira™) in the treatment of US patients with rheumatoid arthritis (RA)
    Bansback, N
    Brennan, A
    Sengupta, N
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 241 - 241
  • [2] The cost-utility of adalimumab (Humira) in patients with rheumatoid arthritis (RA) in Denmark
    Aagren, M.
    Davies, A.
    Pang, F.
    Winding, B.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A223 - A223
  • [3] THE COST-EFFECTIVENESS OF ADALIMUMAB (HUMIRA™) IN PATIENTS WITH RHEUMATOID ARTHRITIS: A UK ANALYSIS
    Bansback, N.
    Brennan, A.
    Sengupta, N.
    Pang, F.
    [J]. RHEUMATOLOGY, 2004, 43 : 77 - 77
  • [4] Cost effectiveness of adalimumab (HUMIRA™, Abbott) in the treatment of patients with moderate to severe rheumatoid arthritis (RA)
    Bansback, NJ
    Brennan, A
    Sengupta, N
    Chang, KY
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S215 - S215
  • [5] The cost-effectiveness of adalimumab (HUMIRA™, Abbott) in patients with rheumatoid arthritis:: A Swedish analysis.
    Bansback, NJ
    Brennan, A
    Ghatnekar, O
    Sengupta, N
    Chang, KY
    Hansen, M
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S611 - S611
  • [6] Workplace impacts of adalimumab (HUMIRA®) in patients with rheumatoid arthritis (RA)
    Birnbaum, Howard
    Pike, Crystal
    Kaufman, Rebecca
    Schiller, Matthew
    Shi, Lizheng
    Sun, Peter
    Ray, Saurabh
    Cifaldi, Mary
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S459 - S459
  • [7] The cost effectiveness of adalimumab (HUMIRA®) in patients with RA:: A Finnish analysis
    Bansback, NJ
    Brennan, A
    Sengupta, N
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 513 - 514
  • [8] Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany
    Gissel, C.
    Goetz, G.
    Repp, H.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2016, 75 (10): : 1006 - 1015
  • [9] COST-EFFECTIVENESS OF ADALIMUMAB FOR RHEUMATOID ARTHRITIS IN GERMANY
    Gissel, C.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A48 - A48
  • [10] The cost effectiveness of adalimumab (HUMIRA®) in UK patients with moderate to severe RA
    Bansback, NJ
    Brennan, A
    Sengupta, N
    Pang, F
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 512 - 513
12345